Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
anti glp 1 antibody Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor Losing weight, but your category:weight-loss-metabolism Colour:Powder Cited in 2 publications
Losing weight, but your joints still hurt? You're not alone. Many people expect joint pain to disappear as soon as they start losing weight on GLP-1 medications. While weight loss often reduces
Pfizer's berobenatide, which delivered Phase 2b data at the American Diabetes Association's 86th Scientific Sessions in June 2026, uses a technique called halo-lipidation that binds albumin at a structurally unique site not used by any existing GLP-1 agent, producing a half-life of approximately 360 hours — about 15 days — roughly three times the human half-life confirmed for TE-8105
category:weight-loss-metabolism
Colour:Powder
[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Suchankova P, et al
Cited in 2 publications
US$ 25.40
US$ 29.84
.png)
US$ 21.50
US$ 23.71
US$ 24.67
US$ 20.61
US$ 26.27
